Combinatorial Treatment of DNA and Chromatin-Modifying Drugs Cause Cell Death in Human and Canine Osteosarcoma Cell Lines
Open Access
- 5 September 2012
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 7 (9), e43720
- https://doi.org/10.1371/journal.pone.0043720
Abstract
Downregulation of microRNAs (miRNAs) at the 14q32 locus stabilizes the expression of cMYC, thus significantly contributing to osteosarcoma (OS) pathobiology. Here, we show that downregulation of 14q32 miRNAs is epigenetically regulated. The predicted promoter regions of miRNA clusters at 14q32 locus showed no recurrent patterns of differential methylation, but Saos2 cells showed elevated histone deacetylase (HDAC) activity. Treatment with 4-phenylbutyrate increased acetylation of histones associated with 14q32 miRNAs, but interestingly, robust restoration of 14q32 miRNA expression, attenuation of cMYC expression, and induction of apoptosis required concomitant treatment with 5-Azacytidine, an inhibitor of DNA methylation. These events were associated with genome-wide gene expression changes including induction of pro-apoptotic genes and downregulation of cell cycle genes. Comparable effects were achieved in human and canine OS cells using the HDAC inhibitor suberoylanilide hydroxamic acid (SAHA/Vorinostat) and the DNA methylation inhibitor Zebularine (Zeb), with significantly more pronounced cytotoxicity in cells whose molecular phenotypes were indicative of aggressive biological behavior. These results suggested that the combination of these chromatin-modifying drugs may be a useful adjuvant in the treatment of rapidly progressive OS.Keywords
This publication has 40 references indexed in Scilit:
- Molecular subtypes of osteosarcoma identified by reducing tumor heterogeneity through an interspecies comparative approachBone, 2011
- Epigenetic modifications as therapeutic targetsNature Biotechnology, 2010
- Localization‐ and mutation‐dependent microRNA (miRNA) expression signatures in gastrointestinal stromal tumours (GISTs), with a cluster of co‐expressed miRNAs located at 14q32.31The Journal of Pathology, 2009
- At Least Ten Genes Define the Imprinted Dlk1-Dio3 Cluster on Mouse Chromosome 12qF1PLOS ONE, 2009
- Osteosarcoma incidence and survival rates from 1973 to 2004Cancer, 2009
- Construction of a 2-Mb resolution BAC microarray for CGH analysis of canine tumorsGenome Research, 2005
- A Large Imprinted microRNA Gene Cluster at the Mouse Dlk1-Gtl2 DomainGenome Research, 2004
- FR901228 induces tumor regression associated with induction of Fas ligand and activation of Fas signaling in human osteosarcoma cellsOncogene, 2003
- MethPrimer: designing primers for methylation PCRsBioinformatics, 2002
- Sporadic amplification of the MYC gene in human osteosarcomas.1993